Dennis Leo Walsh serves as Executive at Deciphera Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Dennis Leo Walsh has executed 2 insider transactions totaling $152.5K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jun 11, 2024 involved transacting 11,000 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jun 11, 2024 | $0 | Tender | 11,000 | $N/A | Discretionary | |
| May 10, 2023 | DCPH | $152.5K | Purchase | 11,000 |
Dennis Leo Walsh currently holds 11,000 shares of Deciphera Pharmaceuticals, Inc. (DCPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Dennis Leo Walsh has been a net buyer of DCPH stock. They have purchased $152.5K and sold $0 worth of shares.
Dennis Leo Walsh's most recent insider trade was on Jun 11, 2024, when they sold 11,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $13.86 |
| Discretionary |